Logo

Compugen to Make Databases Available Through Gencarta Platform

Sep 14, 2000

MIAMI, Sept 14 - Compugen (Nasdaq: CGEN) of Tel Aviv, Israel announced Thursday the launch of Gencarta, a platform that provides access to the company's proprietary annotated genome, transcriptome and proteome databases.

Users of Gencarta will be able to query and browse the genome and gain access to the data on a variety of levels, the company said in a statement.

On the genomic level, researchers will be able to get information about genes and pseudogenes, repeats, CpG islands, SNPs, enhancers, and promoters. On the transcript level information regarding splice variants, aligned ESTs and mRNAs will be available.

Each splice variant will also be annotated with information about homologues, SAGE-based expression profiles, open reading frames, sequence translation, and detailed domain summaries, Compugen said.

In addition Gencarta will provide access to Compugen's LEADS transcriptome database. This database offers thousands of predicted genes and splice variants, putative cSNPs, and annotated genomic information.

The company said its LEADS gene predictions have been tested and verified with a success rate of over 90% in Compugen's molecular biology laboratory.

Gencarta is expected to be commercially available for corporate installation in first-quarter 2001. It will be available on a subscription basis. The company did not disclose information about the cost of a subscription.

Compugen, which has recently repositioned itself as a developer of online bioinformatics tools and proteomics technologies rather than a maker of hardware, operates LabOnWeb.com, a  research portal for life scientists.

 Shares of Compugen were up 5/16, or 1.9 percent, at 17 1/4 in midday trading.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.